2-苯甲酰基氧基甲基苯甲酰氯 | 58249-87-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-苯甲酰基氧基甲基苯甲酰氯
• 中文别名: 2-(苯甲酰氧甲基)苯甲酰氯
• 英文名称: 2-(benzoyloxymethyl)benzoyl chloride
• 英文别名: 2-benzoyloxymethyl benzoic acid chloride；(2-carbonochloridoylphenyl)methyl benzoate
• CAS: 58249-87-9
• 化学式: C₁₅H₁₁ClO₃
• mdl: MFCD00042609
• 分子量: 274.704
• InChiKey: UDEQFYWNFHWPRH-UHFFFAOYSA-N

物化性质

• 熔点：
  59-61 °C
• 沸点：
  407.9±28.0 °C(Predicted)
• 密度：
  1.281±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.066
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2916399090
• 危险品运输编号：
  UN 3261 8/PG 3

反应信息

• 作为反应物：
  描述：

  2-苯甲酰基氧基甲基苯甲酰氯 在 palladium on activated charcoal 吡啶 、 氢气 作用下， 以 乙醇 为溶剂， 生成 2-甲基-N-(4-甲基苯基)苯甲酰胺
  参考文献：
  名称：

  2-Acyloxymethylbenzoic acids. Novel amine protective functions providing amides with the lability of esters

  摘要：

  DOI：

  10.1021/jo00873a032
• 作为产物：
  描述：

  苯酞 在 吡啶 、 氯化亚砜 、 sodium hydroxide 作用下， 以 水 、 甲苯 为溶剂， 反应 1.83h， 生成 2-苯甲酰基氧基甲基苯甲酰氯
  参考文献：
  名称：

  Aziridine ring-containing chiral ligands as highly efficient catalysts in asymmetric synthesis

  摘要：

  Enantiomerically pure bidentate heteroorganic ligands built on an achiral skeleton containing hydroxyl and aziridine moieties as nucleophilic centers, capable of binding various organometallic reagents, have proven to be highly efficient catalysts in the enantioselective addition of diethylzinc and phenylethynylzinc to aryl and alkyl aldehydes to give the desired chiral products in high chemical yields (up to 90%) and with ees of up to 95%. The influence of the stereogenic center located in the carbon atom in the aziridine moiety on the stereochemical course of the reaction is reported. (c) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2013.03.001

文献信息

• Methods for treating an inflammatory condition or inhibiting JNK
  申请人：——

  公开号：US20040127536A1

  公开（公告）日：2004-07-01

  This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

  这项发明通常涉及吲唑衍生物，具有以下结构： 1 或药用可接受的盐，其中R 1 ，R 2 和A如本文所述定义。这类化合物在治疗对JNK抑制剂有响应的广泛疾病和障碍，如炎症性疾病或障碍中具有用途。因此，还披露了治疗这些疾病和障碍的方法，以及包含一个或多个上述化合物的药物组合物。
• Indazole compounds, compositions thereof and methods of treatment therewith
  申请人：Bhagwat S. Shripad

  公开号：US20050009876A1

  公开（公告）日：2005-01-13

  This invention is generally directed to the use of Indazole Compounds for treating or preventing diseases associated with protein kinases, including tyrosine kinases, such as proliferative diseases, inflammatory diseases, abnormal angiogenesis and diseases related thereto, atherosclerosis, macular degeneration, diabetes, obesity, pain and others. The methods comprise the administration to a patient in need thereof of an effective amount of an indazole compound that inhibits, modulates or regulates tyrosine kinase signal transduction. Novel indazole compounds or pharmaceutically acceptable salt thereof are presented herein.

  这项发明通常涉及使用吲唑化合物来治疗或预防与蛋白激酶相关的疾病，包括酪氨酸激酶，诸如增殖性疾病、炎症性疾病、异常血管生成及其相关疾病、动脉硬化、黄斑变性、糖尿病、肥胖、疼痛等。这些方法包括向有需要的患者施用有效量的吲唑化合物，以抑制、调节或控制酪氨酸激酶信号转导。本文中提供了一种新型的吲唑化合物或其药用可接受的盐。
• Cyclisation reactions of 2-substituted benzoylphosphonates with trialkyl phosphites via nucleophilic attack on a carbonyl-containing ortho substituent
  作者：Yuen-Ki Cheong、Philip Duncanson、D. Vaughan Griffiths

  DOI：10.1016/j.tet.2008.01.012

  日期：2008.3

  and dimethyl 2-benzoyloxy-benzoylphosphonate undergo cyclisation and deoxygenation in the presence of excess trimethyl phosphite to give dimethyl (3-methyl-1-benzofuran-2-yl)phosphonate and dimethyl (3-phenyl-1-benzofuran-2-yl)phosphonate, respectively. The reaction pathway has been shown to involve phosphite attack on initially formed tricyclic dioxaphospholane intermediates with the subsequent loss

  在过量亚磷酸三甲酯的存在下，对2-乙酰氧基-二甲基和2-苯甲酰氧基-苯甲酰基膦酸二甲酯进行环化和脱氧，得到（3-甲基-1-苯并呋喃-2-基）膦酸二甲酯和（3-苯基-1-苯并呋喃二甲基）二甲酯。 -2-基）膦酸酯。已显示该反应途径涉及亚磷酸酯对最初形成的三环二氧杂膦烷中间体的攻击，随后损失了两个分子的磷酸三甲酯。在不存在额外的亚磷酸三甲酯的情况下，最初形成的三环二氧杂膦烷中间体会损失一个分子的磷酸三甲酯，然后进行新的重排以生成β-酮膦酸酯。该反应的机理有助于解释一些先前报道的环氧化物重排。相比之下，
• N-Substituted homopiperazine barbiturates as gelatinase inhibitors
  作者：Jun Wang、Carlos Medina、Marek W. Radomski、John F. Gilmer

  DOI：10.1016/j.bmc.2011.06.055

  日期：2011.8

  12-O-tetradecanoylphorbol-13-acetate (PMA)-stimulated HT-1080 cells as well as using recombinant human MMPs. N-Acyl homopiperazine compounds were found to be potent inhibitors of the gelatinases (range in nM) and generally more potent than the corresponding piperazine analogues. The panel of N-acyl homopiperazines was enlarged in order to exploit differences between the gelatinases at the S2′ site in order to design

  基质金属蛋白酶涉及广泛的病理生理过程，并且一直在积极寻求针对这些酶的有效选择性抑制剂。5,5-二取代的巴比妥酸盐有希望成为抑制剂，在体内是稳定的，并且对明胶酶（MMP-2和MMP-9）具有相对选择性。在本文中，我们描述了5-哌嗪和-高哌嗪取代的巴比妥酸酯的合成。使用来自12 - O-十四烷酰phorbol-13-乙酸盐（PMA）刺激的HT-1080细胞的上清液以及使用重组人MMP ，评估了这些化合物作为明胶酶抑制剂的活性。ñ发现酰基高哌嗪化合物是明胶酶的有效抑制剂（范围为nM），通常比相应的哌嗪类似物更有效。N-酰基高哌嗪的面板被扩大，以便利用S2'位点的明胶酶之间的差异，以设计MMP-2-或MMP-9-选择性抑制剂。该组化合物表现出一位数的纳摩尔浓度，并且在两种酶之间具有一定的选择性。代表性的有效化合物是癌细胞迁移的有效抑制剂。
• Scavenger assisted combinatorial process for preparing libraries of amides, carbamates and sulfonamides
  申请人：ELI LILLY AND COMPANY

  公开号：EP0825164A2

  公开（公告）日：1998-02-25

  This invention relates to a novel solution phase process for the preparation of amide, carbamate, and sulfonamide combinatorial libraries. These libraries have utility for drug discovery and are used to form wellplate components of novel assay kits.

  这项发明涉及一种用于制备酰胺、碳酸酯和磺酰胺组合库的新型溶液相过程。这些库在药物发现中具有实用价值，并用于形成新型检测套件的微孔板组件。